MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $657,399 | -32.0% | 40,985 | -1.7% | 0.29% | -29.6% |
Q2 2023 | $966,258 | -0.2% | 41,685 | 0.0% | 0.42% | -4.4% |
Q1 2023 | $968,343 | +159956.7% | 41,685 | 0.0% | 0.43% | +51.7% |
Q4 2022 | $605 | -99.9% | 41,685 | -1.0% | 0.29% | -29.6% |
Q3 2022 | $803,000 | +5.0% | 42,085 | 0.0% | 0.41% | +10.6% |
Q2 2022 | $765,000 | -28.9% | 42,085 | -1.4% | 0.37% | -17.0% |
Q1 2022 | $1,076,000 | -11.8% | 42,685 | -3.4% | 0.44% | -6.9% |
Q4 2021 | $1,220,000 | -11.5% | 44,185 | +3.5% | 0.48% | -23.6% |
Q3 2021 | $1,378,000 | +5.6% | 42,685 | 0.0% | 0.62% | +6.3% |
Q2 2021 | $1,305,000 | +0.4% | 42,685 | 0.0% | 0.58% | -8.0% |
Q1 2021 | $1,300,000 | +54.0% | 42,685 | 0.0% | 0.64% | +43.9% |
Q4 2020 | $844,000 | +51.5% | 42,685 | 0.0% | 0.44% | +32.7% |
Q3 2020 | $557,000 | +15.1% | 42,685 | 0.0% | 0.33% | +6.1% |
Q2 2020 | $484,000 | -21.2% | 42,685 | -0.5% | 0.31% | -34.2% |
Q1 2020 | $614,000 | -47.4% | 42,885 | 0.0% | 0.48% | -36.9% |
Q4 2019 | $1,168,000 | -6.2% | 42,885 | -1.4% | 0.76% | -11.8% |
Q3 2019 | $1,245,000 | +3.1% | 43,485 | 0.0% | 0.86% | +2.9% |
Q2 2019 | $1,208,000 | -16.3% | 43,485 | 0.0% | 0.83% | -15.9% |
Q1 2019 | $1,444,000 | +14.2% | 43,485 | 0.0% | 0.99% | +1.5% |
Q4 2018 | $1,264,000 | -36.8% | 43,485 | 0.0% | 0.98% | -24.2% |
Q3 2018 | $2,000,000 | +21.7% | 43,485 | -1.1% | 1.29% | +10.5% |
Q2 2018 | $1,644,000 | +27.0% | 43,985 | +0.5% | 1.16% | +24.1% |
Q1 2018 | $1,294,000 | -14.0% | 43,785 | 0.0% | 0.94% | -16.9% |
Q4 2017 | $1,504,000 | -5.3% | 43,785 | -0.2% | 1.13% | -13.2% |
Q3 2017 | $1,588,000 | +40.0% | 43,885 | 0.0% | 1.30% | +36.5% |
Q2 2017 | $1,134,000 | +34.5% | 43,885 | 0.0% | 0.95% | +34.2% |
Q1 2017 | $843,000 | +15.2% | 43,885 | 0.0% | 0.71% | +8.7% |
Q4 2016 | $732,000 | -19.8% | 43,885 | -1.1% | 0.65% | -20.0% |
Q3 2016 | $913,000 | -32.9% | 44,385 | -0.2% | 0.82% | -34.5% |
Q2 2016 | $1,361,000 | -63.5% | 44,485 | -56.7% | 1.25% | -24.0% |
Q1 2016 | $3,730,000 | +89.3% | 102,785 | +125.2% | 1.64% | -8.5% |
Q4 2015 | $1,970,000 | -8.3% | 45,635 | -20.4% | 1.80% | -9.0% |
Q3 2015 | $2,149,000 | +9.3% | 57,350 | -0.9% | 1.97% | +15.6% |
Q2 2015 | $1,966,000 | -4.0% | 57,850 | 0.0% | 1.71% | -2.6% |
Q1 2015 | $2,048,000 | +3.5% | 57,850 | -0.4% | 1.75% | -0.7% |
Q4 2014 | $1,979,000 | – | 58,100 | – | 1.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |